Try our beta test site

Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)

This study has been completed.
Tufts Medical Center
National Cancer Institute (NCI)
Ligand Pharmaceuticals
Information provided by:
Eisai Inc. Identifier:
First received: September 13, 2005
Last updated: February 29, 2008
Last verified: February 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2006
  Primary Completion Date: January 2005 (Final data collection date for primary outcome measure)